For: |
Rogers ME, Balistreri WF. Cascade of care for children and adolescents with chronic |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i12/1117.htm |
Number | Citing Articles |
1 |
Jonathan R. Honegger, Charitha Gowda. Defer no more: advances in the treatment and prevention of chronic hepatitis C virus infection in children. Current Opinion in Infectious Diseases 2022; 35(5): 468 doi: 10.1097/QCO.0000000000000856
|
2 |
Megan Rose Curtis, Catherine Chappell. Evidence for Implementation: HIV/HCV Coinfection and Pregnancy. Current HIV/AIDS Reports 2023; 20(1): 1 doi: 10.1007/s11904-022-00643-9
|
3 |
Maria Pokorska-Śpiewak, Anna Dobrzeniecka, Małgorzata Aniszewska, Magdalena Marczyńska. Real-Life Experience with Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Virus Infection with Genotypes 1 and 4 in Children Aged 12 to 17 Years—Results of the POLAC Project. Journal of Clinical Medicine 2021; 10(18): 4176 doi: 10.3390/jcm10184176
|
4 |
Lucie Hozáková, Barbora Vokatá, Tomáš Ruml, Pavel Ulbrich. Targeting the Virus Capsid as a Tool to Fight RNA Viruses. Viruses 2022; 14(2): 174 doi: 10.3390/v14020174
|
5 |
Jinling Dong, Tiantian Wu, Ying Zhang, Zhihong Xie, Jie He. Transcriptome and MicroRNAs Profiling Analysis of Huh7.5.1 Cells in Response to Hepatitis C Virus Infection. Hepatitis Monthly 2021; 21(8) doi: 10.5812/hepatmon.118724
|
6 |
Chen Wang, Weiran Qi, Ting Yang, Lirui Jiao, Qiushi Chen, Ke Huang, Fengyun Yu, Pascal Geldsetzer, Till Bärnighausen, Simiao Chen. The care cascade of chronic obstructive pulmonary disease in China: a cross-sectional study of individual-level data at enrolment into the national ‘Happy Breathing’ Programme. eClinicalMedicine 2024; 74: 102597 doi: 10.1016/j.eclinm.2024.102597
|
7 |
Maria Pokorska-Śpiewak, Anna Dobrzeniecka, Magdalena Marczyńska. One-Year Outcomes after Ledipasvir/Sofosbuvir Treatment of Chronic Hepatitis C in Teenagers with and without Significant Liver Fibrosis—A Case Series Report. Viruses 2021; 13(8): 1518 doi: 10.3390/v13081518
|
8 |
Jessica Tuan, Adaora Okoli, Onyema Ogbuagu. Pharmacokinetic evaluation of sofosbuvir/velpatasvir for the treatment of Chronic Hepatitis C in pediatrics aged 3 and older. Expert Opinion on Drug Metabolism & Toxicology 2023; 19(12): 881 doi: 10.1080/17425255.2023.2292736
|
9 |
T. L. Manaenkova, T. A. Bairova, A. Yu. Sambyalova, A. I. Paramonov, E. V. Belyaeva, O. V. Bugun, L. V. Rychkova. Comorbid disease in children and adolescents with perinatal HIV infection: A pilot study. Acta Biomedica Scientifica 2022; 7(5-2): 74 doi: 10.29413/ABS.2022-7.5-2.8
|
10 |
Nouhoum Bouare, Mamadou Keita, Jean Delwaide. Comment on review article: Chronic hepatitis C virus infection cascade of care in pediatric patients. World Journal of Gastroenterology 2022; 28(14): 1494-1498 doi: 10.3748/wjg.v28.i14.1494
Abstract(621) |
Core Tip(676) |
Full Article(HTML)(1970)
|
Full Article (PDF)-1845K(283)
|
Full Article (Word)-111K(118)
|
Audio-92K(0)
|
Peer-Review Report-243K(89)
|
Answering Reviewers-226K(85)
|
Times Cited (0)
|
Total Visits (5405)
|
Open
|
11 |
Zixuan Feng, Qiushi Chen, Lirui Jiao, Xuedi Ma, Rifat Atun, Pascal Geldsetzer, Till Bärnighausen, Simiao Chen. The impact of health insurance on hypertension care: a household fixed effects study in India. BMC Public Health 2024; 24(1) doi: 10.1186/s12889-024-19759-1
|
12 |
Muhammad Abdel‐Gawad, Sherief Abd‐elsalam, Ibrahim Abdel‐Gawad, Mohammed Tag‐Adeen, Marwa El‐Sayed, Dalia Abdel‐Malek. Seroprevalence of hepatitis C virus infection in children: A systematic review and meta‐analysis. Liver International 2022; 42(6): 1241 doi: 10.1111/liv.15212
|
13 |
Maria Pokorska-Śpiewak, Anna Dobrzeniecka, Agnieszka Ogrodnik. Efficacy and Safety of the Treatment of Chronic Hepatitis C with Sofosbuvir/Ledipasvir in Children Aged 5 to 10 Years with Comorbidities—A Brief Report. Infectious Disease Reports 2022; 14(4): 574 doi: 10.3390/idr14040061
|